Top Story

All biologics increase risk for tuberculosis

December 31, 2019

Read the Perspective from Carrie Beach, BSN, RN-BC

Meeting News

Low clinical value in repeat latent tuberculosis tests in patients taking biologics

November 14, 2019
Repeat, routine testing for latent tuberculosis infection among patients receiving biologics is both costly and of low clinical value, according to findings presented at…
In the Journals

Xpert Ultra assay identifies pediatric TB with high sensitivity

October 30, 2019
An updated version of the Xpert Mycobacterium tuberculosis and rifampin assay, known as Ultra, demonstrated high sensitivity in diagnosing pulmonary tuberculosis in…

World Lung Day 2019: A focus on universal health coverage

September 25, 2019
Today marks World Lung Day, and this year’s theme is “healthy lungs for all.” To raise awareness, medical societies, advocacy groups and other…
More Headlines »
Special Issue Article

When the Great Masquerader Reveals Itself—Tuberculosis

Pediatric Annals, February 2017, Volume 46 Issue 2
Pneumonia is a clinical diagnosis often treated empirically and successfully on an outpatient basis. When a patient…
More »

Xpert MTB/RIF Ultra: Another advance in TB diagnostics

Infectious Disease News, January 2018
David L Cohn, MD
The development of the Xpert MTB/RIF assay has been the most important breakthrough for the diagnosis of tuberculosis…
More »
Meeting News Coverage

VIDEO: Mel Spigelman, MD, discusses TB drug pipeline

June 19, 2016
More »
Healio Jobs